JAGUAR HEALTH, INC. Inventory
JAGUAR HEALTH, INC. (JAGX) had Inventory of $7.32 million as of 2026-06-30, per its 10-Q filed 2026-08-19.
Financial Statements › Balance Sheet › Assets › Assets, Current › Inventory, Net
us-gaap:InventoryNet · last filed 2026-08-19
- 2026-06-30: Inventory, Net $7.32M.
- 2026-03-31: Inventory, Net $7.82M.
- 2025-12-31: Inventory, Net $8.60M.
- 2025-09-30: Inventory, Net $10.63M.
| Period end | Inventory, Net | Inventory, Net as first filed |
|---|---|---|
| 2026-06-30 | $7.32M 10-Q · filed 2026-08-19 | |
| 2026-03-31 | $7.82M 10-Q · filed 2026-05-20 | |
| 2025-12-31 | $8.60M 10-Q · filed 2026-08-19 | |
| 2025-09-30 | $10.63M 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $10.72M 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $10.55M 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $10.35M 10-K · filed 2026-04-07 | |
| 2024-09-30 | $9.67M 10-Q · filed 2024-11-13 | |
| 2024-06-30 | $9.56M 10-Q · filed 2024-08-13 | |
| 2024-03-31 | $9.02M 10-Q · filed 2024-05-14 | |
| 2023-12-31 | $9.19M 10-K · filed 2025-03-31 | |
| 2023-09-30 | $8.38M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $8.26M 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $8.68M 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $7.02M 10-K · filed 2024-04-01 | |
| 2022-09-30 | $6.60M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $6.75M 10-Q · filed 2022-08-22 | |
| 2022-03-31 | $4.88M 10-Q · filed 2022-05-10 | |
| 2021-12-31 | $4.90M 10-K · filed 2023-03-24 | |
| 2021-09-30 | $4.51M 10-Q · filed 2021-11-17 | |
| 2021-06-30 | $3.40M 10-Q · filed 2021-08-13 | |
| 2021-03-31 | $2.82M 10-Q · filed 2021-05-17 | |
| 2020-12-31 | $2.78M 10-K · filed 2022-03-11 | |
| 2020-09-30 | $2.22M 10-Q · filed 2020-11-16 | |
| 2020-06-30 | $2.35M 10-Q · filed 2020-08-13 | |
| 2020-03-31 | $2.70M 10-Q · filed 2020-05-15 | |
| 2019-12-31 | $2.13M 10-K · filed 2021-03-31 | $2.13M 10-K · filed 2020-04-03 |
| 2019-09-30 | $2.32M 10-Q · filed 2019-11-14 | |
| 2019-06-30 | $2.39M 10-Q · filed 2019-08-14 | |
| 2019-03-31 | $2.96M 10-Q · filed 2019-05-21 | |
| 2018-12-31 | $3.34M 10-K · filed 2020-04-03 | |
| 2018-09-30 | $2.55M 10-Q · filed 2018-11-19 | |
| 2018-06-30 | $2.84M 10-Q · filed 2018-08-13 | |
| 2018-03-31 | $2.33M 10-Q · filed 2018-05-15 | |
| 2017-12-31 | $2.07M 10-K · filed 2019-04-10 | |
| 2017-09-30 | $1.83M 10-Q · filed 2017-11-20 | |
| 2017-06-30 | $396.18K 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $392.64K 10-Q/A · filed 2017-06-23 | |
| 2016-12-31 | $412.75K 10-K · filed 2018-04-09 | |
| 2016-09-30 | $276.23K 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $276.62K 10-Q · filed 2016-08-15 | |
| 2016-03-31 | $269.63K 10-Q · filed 2016-05-10 | |
| 2015-12-31 | $229.87K 10-K · filed 2017-02-15 | |
| 2015-09-30 | $256.13K 10-Q · filed 2015-11-13 | |
| 2015-06-30 | $306.72K 10-Q · filed 2015-08-13 | |
| 2015-03-31 | $314.21K 10-Q · filed 2015-06-26 | |
| 2014-12-31 | $198.03K 10-K · filed 2016-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |